{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T14:33:36Z","timestamp":1710858816187},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.sleep.2006.08.015","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T11:00:49Z","timestamp":1174561249000},"page":"260-265","source":"Crossref","is-referenced-by-count":5,"title":["Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Oludare B.","family":"Taiwo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Jon","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel E.","family":"Michalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie M.","family":"Zeitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2006.08.015_bib1","first-page":"69","article-title":"Hypersomnolence in fibromyalgia syndrome","volume":"20","author":"Sarzi-Puttini","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2006.08.015_bib3","first-page":"1407","article-title":"The prevalence and meaning of fatigue in rheumatic disease","volume":"23","author":"Wolfe","year":"1996","journal-title":"Source J Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02229884","article-title":"Clinical screening for narcolepsy\/cataplexy in patients with fibromyalgia","volume":"13","author":"Disdier","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0987-7053(00)00240-9","article-title":"Sleep in fibromyalgia: review of clinical and polysomnographic data","volume":"31","author":"Dauvilliers","year":"2001","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.sleep.2006.08.015_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","article-title":"Musculosketal symptoms and non-REM sleep disturbance in patients with \u201cfibrositis syndrome\u201d and healthy subjects","volume":"37","author":"Moldofsky","year":"1975","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sleep.2006.08.015_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0011-8532(22)00489-X","article-title":"Disordered sleep in fibromyalgia and related myofascial facial pain conditions","volume":"45","author":"Moldofsky","year":"2001","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.sleep.2006.08.015_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1389-9457(00)00028-9","article-title":"Nighttime sleep and daytime functioning (sleepiness and fatigue) in less well-defined chronic rheumatic diseases with particular reference to the \u2019alpha\u2013delta NREM sleep anomaly","volume":"1","author":"Mahowald","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2006.08.015_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780380906","article-title":"Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia","volume":"38","author":"Carette","year":"1995","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.sleep.2006.08.015_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0304-3959(96)03226-5","article-title":"Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia","volume":"68","author":"Affleck","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.sleep.2006.08.015_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(02)00300-7","article-title":"The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia","volume":"100","author":"Nicassio","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.sleep.2006.08.015_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.86.3.1034","article-title":"Circadian rhythms of women with fibromyalgia","volume":"86","author":"Klerman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.sleep.2006.08.015_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2006.08.015_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.sleep.2006.08.015_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.sleep.2006.08.015_bib16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2006.08.015_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.sleep.2006.08.015_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1113\/jphysiol.2001.013120","article-title":"Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat","volume":"538","author":"Grudt","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.sleep.2006.08.015_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704851","article-title":"Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test","volume":"137","author":"Yamamoto","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2006.08.015_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(00)00470-X","article-title":"Orexin-A, an hypothalamic peptide with analgesic properties","volume":"92","author":"Bingham","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.sleep.2006.08.015_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1124\/jpet.103.056663","article-title":"Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain","volume":"307","author":"Cheng","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2006.08.015_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-291X(03)00299-7","article-title":"Regulation of orexin neurons by the monoaminergic and cholinergic systems","volume":"303","author":"Yamanaka","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sleep.2006.08.015_bib23","first-page":"119","article-title":"Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats","volume":"18","author":"Suyama","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.sleep.2006.08.015_bib24","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.sleep.2006.08.015_bib25","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1523\/JNEUROSCI.19-08-03171.1999","article-title":"Hypothalamic hypocretin (orexin): robust innervation of the spinal cord","volume":"19","author":"van Den Pol","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.sleep.2006.08.015_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(200002)13:1<51::AID-ART8>3.0.CO;2-Q","article-title":"A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis","volume":"13","author":"Catley","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.sleep.2006.08.015_bib27","first-page":"299","article-title":"Responses of the sympathetic nervous system and the hypothalamic\u2013pituitary\u2013adrenal axis to interleukin-6: a pilot study in fibromyalgia","volume":"4","author":"Torpy","year":"2000","journal-title":"Curr Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0889-857X(05)70180-0","article-title":"Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome","volume":"26","author":"Neeck","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.sleep.2006.08.015_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11926-002-0038-5","article-title":"Evidence of involvement of central neural mechanisms in generating fibromyalgia pain","volume":"4","author":"Staud","year":"2002","journal-title":"Curr Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology criteria for the classification of fibromyalgia","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2006.08.015_bib31","first-page":"S614","article-title":"Therapy with a central alpha-2-agonist [tizanidine] decreases cerebrospinal fluid substance P, and may reduce serum hyaluronic acid as it improves the clinical symptoms of the fibromyalgia syndrome","volume":"46","author":"Russell","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2006.08.015_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2006.08.015_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/art.1780371106","article-title":"Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome","volume":"37","author":"Russell","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2006.08.015_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0895-4356(88)90138-2","article-title":"A scale for the estimation of sleep problems in clinical research","volume":"41","author":"Jenkins","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sleep.2006.08.015_bib35","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib36","first-page":"789","article-title":"The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1016\/j.sleep.2006.08.015_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale","volume":"12","author":"Zung","year":"1965","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.sleep.2006.08.015_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000395075","article-title":"The measurement of affects: depression and anxiety","volume":"7","author":"Zung","year":"1974","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1016\/j.sleep.2006.08.015_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/art.1780340507","article-title":"Treatment of primary fibrositis\/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study","volume":"34","author":"Russell","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2006.08.015_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.0953-816x.2001.01725.x","article-title":"Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light\u2013dark cycle and sleep\u2013wake activities","volume":"14","author":"Yoshida","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.sleep.2006.08.015_bib41","first-page":"1079","article-title":"Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement","volume":"283","author":"Wu","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.sleep.2006.08.015_bib42","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J Neurosci"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945706006010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945706006010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T04:02:41Z","timestamp":1683777761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945706006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1389945706006010"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2006.08.015","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}